Medicine guide

HETRONIFLY

As listed in the register: HETRONIFLY 10 mg/mL, solution à diluer pour perfusion

10 mg · solution à diluer pour perfusion

  • Prescription only
Active substance
Serplulimab
Made by
ACCORD HEALTHCARE (ESPAGNE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byACCORD HEALTHCARE (ESPAGNE)
Active substanceSerplulimab
Strength10 mg
Formsolution à diluer pour perfusion
Routeintraveineuse
Dispensing (as stated by the register)réservé à l'usage HOSPITALIER · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/24/1870
Name in the registerHETRONIFLY 10 mg/mL, solution à diluer pour perfusion
Packs1 flacon(s) en verre de 10 ml
CIS68851406
CIP133400955104575

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).